This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valk, P. J. M.
Right arrow Articles by Delwel, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valk, P. J. M.
Right arrow Articles by Delwel, R.

 Previous Article  |  Next Article 

Journal of Virology, May 1999, p. 3595-3602, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Retroviral Insertions in Evi12, a Novel Common Virus Integration Site Upstream of Tra1/Grp94, Frequently Coincide with Insertions in the Gene Encoding the Peripheral Cannabinoid Receptor Cnr2

Peter J. M. Valk,1 Yolanda Vankan,1 Marieke Joosten,1 Nancy A. Jenkins,2 Neal G. Copeland,2 Bob Löwenberg,1 and Ruud Delwel1,*

Institute of Hematology, Erasmus University Rotterdam, 3000 DR, Rotterdam, The Netherlands,1 and Mammalian Genetics Laboratory, ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Frederick, Maryland 217022

Received 26 October 1998/Accepted 20 January 1999

The common virus integration site (VIS) Evi11 was recently identified within the gene encoding the hematopoietic G-protein-coupled peripheral cannabinoid receptor Cnr2 (also referred to as Cb2). Here we show that Cnr2 is a frequent target (12%) for insertion of Cas-Br-M murine leukemia virus (MuLV) in primary tumors in NIH/Swiss mice. Multiple provirus insertions in Evi11 were cloned and shown to be located within the 3' untranslated region of the candidate proto-oncogene Cnr2. These results suggest that proviral insertion in the Cnr2 gene is an important step in Cas-Br-M MuLV-induced leukemogenesis in NIH/Swiss mice. To isolate Evi11/Cnr2 collaborating proto-oncogenes, we searched for novel common VISs in the Cas-Br-M MuLV-induced primary tumors and identified a novel frequent common VIS, Evi12 (14%). Interestingly, 54% of the Evi11/Cnr2-rearranged primary tumors contained insertions in Evi12 as well, which suggests cooperative action of the target genes in these two common VISs in leukemogenesis. By interspecific backcross analysis it was shown that Evi12 resides on mouse chromosome 10 in a region that shares homology with human chromosomes 12q and 19p. Sequence analysis demonstrated that Evi12 is located upstream of the gene encoding the molecular chaperone Tra1/Grp94, which was previously mapped to mouse chromosome 10 and human chromosome 12q22-24. Thus, Tra1/Grp94 is a candidate target gene for retroviral activation or inactivation in Evi12. However, Northern and Western blot analyses did not provide evidence that proviral insertion had altered the expression of Tra1/Grp94. Additional studies are required to determine whether Tra1/Grp94 or another candidate proto-oncogene in Evi12 is involved in leukemogenesis.

* Corresponding author. Mailing address: Institute of Hematology, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands. Phone: 31104087843. Fax: 31104362315. E-mail: Delwel{at}hema.fgg.eur.nl.

Journal of Virology, May 1999, p. 3595-3602, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • van den Akker, E., Vankan-Berkhoudt, Y., Valk, P. J. M., Lowenberg, B., Delwel, R. (2005). The Common Viral Insertion Site Evi12 Is Located in the 5'-Noncoding Region of Gnn, a Novel Gene with Enhanced Expression in Two Subclasses of Human Acute Myeloid Leukemia. J. Virol. 79: 5249-5258 [Abstract] [Full Text]  
  • Casellas, P. (2004). CB2, a paradigm for a novel class of "onco-GPCRs"?. Blood 104: 302-303 [Full Text]  
  • Jorda, M. A., Lowenberg, B., Delwel, R. (2003). The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation. Blood 101: 1336-1343 [Abstract] [Full Text]  
  • Erkeland, S. J., Valkhof, M., Heijmans-Antonissen, C., Delwel, R., Valk, P. J. M., Hermans, M. H. A., Touw, I. P. (2003). The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation. Blood 101: 1111-1117 [Abstract] [Full Text]  
  • Alberich Jorda, M., Verbakel, S. E., Valk, P. J. M., Vankan-Berkhoudt, Y. V., Maccarrone, M., Finazzi-Agro, A., Lowenberg, B., Delwel, R. (2002). Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol. Blood 99: 2786-2793 [Abstract] [Full Text]  
  • Sanchez, C., de Ceballos, M. L., del Pulgar, T. G., Rueda, D., Corbacho, C., Velasco, G., Galve-Roperh, I., Huffman, J. W., Ramon y Cajal, S., Guzman, M. (2001). Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor. Cancer Res. 61: 5784-5789 [Abstract] [Full Text]  
  • Klein, T. W., Lane, B., Newton, C. A., Friedman, H. (2000). The Cannabinoid System and Cytokine Network. Exp. Biol. Med. 225: 1-8 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»